Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.43B |
| 2 |
Microsoft
MSFT
|
+$671M |
| 3 |
Spotify
SPOT
|
+$586M |
| 4 |
iShares Bitcoin Trust
IBIT
|
+$456M |
| 5 |
Eli Lilly
LLY
|
+$406M |
Top Sells
| 1 |
Apple
AAPL
|
+$2.7B |
| 2 |
Amazon
AMZN
|
+$1.48B |
| 3 |
Merck
MRK
|
+$884M |
| 4 |
Broadcom
AVGO
|
+$823M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$698M |
Sector Composition
| 1 | Technology | 15.81% |
| 2 | Healthcare | 13.31% |
| 3 | Financials | 13.08% |
| 4 | Industrials | 11.5% |
| 5 | Consumer Discretionary | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1276
MSC Industrial Direct
MSM
$5.09B
| $13.3M | 0.01% |
154,062
+34,362
| +29% | +$2.96M |
|
1277
Molina Healthcare
MOH
$9.8B
| $13.3M | 0.01% |
38,475
-312,631
| -89% | -$108M |
|
1278
AMC Networks
AMCX
$357M
| $13.2M | 0.01% |
1,523,404
+1,280,959
| +528% | +$11.1M |
|
1279
Cullinan Oncology
CGEM
$386M
| $13.2M | 0.01% |
+788,567
| New | +$13.2M |
|
1280
Global Ship Lease
GSL
$1.14B
| $13.2M | 0.01% |
495,245
+323,574
| +188% | +$8.62M |
|
1281
Skywest
SKYW
$4.35B
| $13.2M | 0.01% |
155,166
-290,824
| -65% | -$24.7M |
|
1282
Johnson & Johnson
JNJ
$429B
| $13.2M | 0.01% |
81,373
-995,600
| -92% | -$161M |
|
1283
Terns Pharmaceuticals
TERN
$633M
| $13.2M | 0.01% |
1,578,534
+438,142
| +38% | +$3.65M |
|
1284
Vera Therapeutics
VERA
$1.52B
| $13.1M | 0.01% |
296,435
+263,038
| +788% | +$11.6M |
|
1285
Personalis
PSNL
$519M
| $13.1M | 0.01% |
2,435,352
+2,314,488
| +1,915% | +$12.5M |
|
1286
Tourmaline Bio
TRML
$1.22B
| $13.1M | 0.01% |
+509,415
| New | +$13.1M |
|
1287
Mettler-Toledo International
MTD
$25.9B
| $13.1M | 0.01% |
8,726
-8,810
| -50% | -$13.2M |
|
1288
OneSpaWorld
OSW
$2.24B
| $13.1M | 0.01% |
791,065
-234,002
| -23% | -$3.86M |
|
1289
Westlake Corp
WLK
$11.3B
| $13M | 0.01% |
86,758
-44,858
| -34% | -$6.74M |
|
1290
nCino
NCNO
$3.48B
| $13M | 0.01% |
412,454
-1,039,788
| -72% | -$32.8M |
|
1291
Rocket Companies
RKT
$44.4B
| $13M | 0.01% |
678,027
+257,924
| +61% | +$4.95M |
|
1292
Rollins
ROL
$27.8B
| $13M | 0.01% |
256,253
-182,790
| -42% | -$9.25M |
|
1293
Blue Owl Capital
OBDC
$7.23B
| $13M | 0.01% |
889,163
-681,613
| -43% | -$9.93M |
|
1294
Kiniksa Pharmaceuticals
KNSA
$2.75B
| $12.9M | 0.01% |
516,526
-105,422
| -17% | -$2.63M |
|
1295
Greif
GEF
$3.59B
| $12.9M | 0.01% |
205,418
-10,099
| -5% | -$633K |
|
1296
Soleno Therapeutics
SLNO
$2.85B
| $12.9M | 0.01% |
254,889
-203,631
| -44% | -$10.3M |
|
1297
Badger Meter
BMI
$5.24B
| $12.9M | 0.01% |
58,889
-41,899
| -42% | -$9.15M |
|
1298
i3 Verticals
IIIV
$724M
| $12.9M | 0.01% |
603,106
-70,840
| -11% | -$1.51M |
|
1299
Jack in the Box
JACK
$350M
| $12.8M | 0.01% |
275,617
+94,424
| +52% | +$4.39M |
|
|
AVDL
1300
Avadel Pharmaceuticals
AVDL
$1.5B
| $12.8M | 0.01% |
978,018
+964,257
| +7,007% | +$12.6M |
|